Vitamin D deficiency is a major environmental risk factor for the development of multiple 1 sclerosis (MS). The major circulating metabolite of vitamin D (25OHD) is converted to the 2 active form (calcitriol) by the hydroxylase enzyme CYP27B1. In MS lesions the tyrosine kinase 3
Introduction 15
Vitamin D deficiency is a major environmental risk factor for the development of multiple 16 sclerosis (MS) (1). Although widely prescribed for patients with MS, the impact of vitamin D on 17 disease course and severity, as well as its mechanisms of action, are poorly understood. Active 18 vitamin D (calcitriol) is obtained from the cutaneous production of vitamin D3 (cholecalciferol) 19 in the presence of sufficient ultraviolet B irradiation, as well as limited dietary sources. 20
Cholecalciferol is converted to 25-hydroxyvitamin D (25OHD; calcifediol), the major circulating 21 metabolite, and then to hormonally active 1,25-dihyroxyvitamin D (1,25(OH) 2 D; calcitriol) 22 through sequential hydroxylation, catalyzed by 25-hydroxylases (CYP2R1, CYP27A1) and 25-23 hydroxyvitamin D 3 1-alpha-hydroxylase (CYP27B1), respectively (2). Levels of 25OHD are 24 used clinically to assess vitamin D status (3). Calcitriol functions as a ligand for the vitamin D 25 receptor, a member of the nuclear receptor family of hormone-regulated transcription factors (3). 26
Catabolism of 25OHD and calcitriol is initiated by the CYP24A1 enzyme, whose expression is 27 tightly regulated by calcitriol in a negative feedback loop. CYP27B1 is abundantly expressed in 28 most biological systems, allowing for local calcitriol production in several tissues, including the 29 central nervous system (CNS). Importantly, CYP27B1 expression is regulated by a complex 30 cytokine network in immune cells, including cells of myeloid origin (4). 31 32 Cells of myeloid lineage, including endogenous microglia and infiltrating monocyte-derived 33 macrophages (MDMs), are the dominant cell population within active MS lesions (5). We have 34 previously shown that the myeloid cell-mediated phagocytic clearance of myelin debris, a 35 process required for efficient remyelination, is regulated by MerTK, a member of the TAM 36 family of receptor tyrosine kinases (6). MerTK deficiency results in delayed remyelination in the 37 regulate the intracellular levels of calcitriol have been associated with an increased risk of MS 48 (11) (12, 13) . 49 50
In the current study, we investigated calcitriol-mediated transcriptomic regulation of human 51
MDMs and microglia. RNA sequencing revealed significant calcitriol-mediated negative 52 regulation of both phagocytic and antigen-presenting pathways in these cell types. We 53 demonstrate that calcitriol represses MerTK expression and phagocytic capacity of primary 54 myeloid cells and significantly downregulates components of the antigen presentation pathway. 55
Notably, proinflammatory myeloid cells expressing the lowest levels of MerTK have the most 56 active vitamin D metabolic processing pathway and are therefore able to respond to the precursor 57 25OHD. In contrast, lack of endogenous processing of 25OHD in homeostatic myeloid cells 58 maintains high MerTK expression and therefore participation in the immunologically-silent 59 clearance of myelin debris and apoptotic cells. 60 RNA sequencing: Control and calcitriol treated MDMs and microglia were collected in TRIzol 106 reagent (Invitrogen) and RNA was extracted according to the manufacturer's protocol (Qiagen) . 107
Smart-Seq2 libraries were prepared by the Broad Technology Labs and sequenced by the Broad 108 Genomics Platform. cDNA libraries were generated the Smart-seq2 protocol (15). RNA 109 sequencing was performed using Illumina NextSeq500 using a High Output v2 kit to generate 2 110 × 25 bp reads. Reads were aligned to the GRCh38 genome with STAR aligner and quantified by 111 the BTL computational pipeline using Cuffquant version 2.2.1 (16, 17) . Raw counts were 112 normalized using TMM normalization and then log2-transformed. The read counts for each 113 sample were used for differential expression analysis with the edgeR package (18, 19) . The 114 differentially-expressed genes were identified using p-value < 0.05 and log2 fold change > 1. 115
Principle component analysis (PCA) was carried out using built-in R function, prcomp, and 116 visualized using gplot package. Heatmaps were created using ggplot2 package in R. The full list 117 of identified genes was used to generate volcano plots in R. For PCA and heatmap graphs, 118 variance of genes across all macrophage phenotypes was calculated and the top 500 highly 119 variable genes were used for further analysis. 120 qPCR: Cells were lysed in TRIzol (Invitrogen). Total RNA extraction was performed using 121 standard protocols followed by DNAse treatment according to the manufacturer's instructions 122 (Qiagen) . For gene expression analysis, random hexaprimers and Moloney murine leukemia 123 virus reverse transcriptase were used to perform standard reverse transcription. Analysis of 124 individual gene expression was conducted using TaqMan probes to assess expression relative to 125 MERTK (Fig. 1A) . 138
To examine the effect of calcitriol on MDMs in different states of polarization (supplementary 139 Fig. 1A and B) , we analyzed the transcriptomic profile of homeostatic (MØ 0 ) and 140 proinflammatory (MØ GMcsf ) MDMs generated in vitro and subjected to bulk RNA sequencing. 141 MØ 0 show high expression of CNS homeostatic myeloid markers such as TREM2, CSF1R, IL10 142 and Mafb (supplementary Fig. 1C ). Proinflammatory MØ GMcsf cells expression signatures show 143 typical inflammatory markers such as IL6, NLRP1, ITGAX, CCL22, MMP9 and ITGAX, as well 144 as induction of inflammatory programs involving the transcription factor BHLHE40, identified as 145 part of the disease-associated transcriptomic signature (21). PCA ( Fig. 1B) and heatmap (Fig. 146 1C) analyses showed that MØ 0 and MØ GMcsf cells cluster separately based on their phenotypes 147 with calcitriol treated cells clustering together regardless of their starting phenotype (Fig. 1B, C) . 148
Volcano plot analysis confirms this calcitriol-mediated shift in the transcriptomic signature and 149 highlights that both phenotypes responded to calcitriol by upregulating known calcitriol target 150 genes CYP24A1 and cathelicidin (CAMP) (Fig. 1D ). Finally, over-representation analysis (ORA) 151 was carried out using significantly differentially expressed genes in both MØ 0 and MØ GMcsf cells 152 exposed to calcitriol ( Fig.1E ). Set nodes represent biological processes colored based on p-value 153 (red-light yellow; most significant-least significant). The size of the node corresponds to the 154 number of genes associated with that biological process. Smaller unlabeled nodes represent 155 individual genes (red: upregulated; green: downregulated). Down-regulated genes of interest 156 (MERTK and HLA-DRB1) with their link to relevant biological processes (regulation of 157 endocytosis and adaptive immune response) are highlighted. 158 159
Calcitriol regulation of MerTK expression and function in human MDMs: Use of the Ingenuity 160
Pathway Analysis (IPA) bioinformatic tool highlighted 'phagosome formation' as one of the top 161 canonical pathways affected by calcitriol in MDMs (supplementary Fig. 2 ). Visualization of this 162 pathway highlighted the downregulation of a number of phagocytic and immune-sensing 163 receptors including complement receptors, Fc receptors, and integrins ( Fig. 2A ). We identified a 164 list of 30 genes associated with phagocytosis by myeloid cells and assessed their expression in 165 response to calcitriol in both MØ 0 and MØ GMcsf cells (Table 1 ). A total of 7 genes were 166 significantly downregulated in MØ 0 and 4 in MØ GMcsf in response to calcitriol treatment. MERTK 167 was the only gene significantly downregulated in both MØ 0 and MØ GMcsf cells (Fig. 2B ). We 168 validated this RNAseq finding by RT-qPCR. Regardless of phenotype, calcitriol significantly 169 downregulated MERTK mRNA ( Fig. 2C ) and protein expression, as measured by flow cytometry 170 ( Fig. 2D ). 171
To assess if reduced expression of MerTK would have a functional impact on the cells, we 172 measured the ability of calcitriol-treated MDMs to phagocytose myelin debris, autologous 173
apoptotic T-cells, and opsonized red blood cells (RBCs). Calcitriol-treated MDMs displayed a 174 reduced capacity to phagocytose pHRhodamine-labelled human myelin, regardless of cellular 175 phenotype ( Fig. 2E) . 176
In addition to myelin, MerTK has been extensively characterized as a mediator of apoptotic cell 177 clearance (9). To investigate whether calcitriol also inhibited this process, pHRhodamine-178 labelled apoptotic T-cells were incubated with autologous MDMs. We observed a significant 179 inhibition of apoptotic T-cell phagocytosis by calcitriol-exposed MØ 0 but not MØ GMcsf cells. 180 This is indicative of a MØ GMcsf -specific efferocytotic receptor that can compensate for the 181 calcitriol-mediated downregulation of MerTK. (Fig. 2F ). Finally, to validate the specificity of 182 calcitriol in regulating MerTK-dependent phagocytosis, we assessed the uptake of opsonized 183 RBCs (oRBCs) by both MDM phenotypes. Phagocytosis of oRBCs occurs through Fc-receptor-184 mediated endocytosis, a MerTK-independent pathway. In all cases, calcitriol had no influence on 185 the ability of MDMs to phagocytose oRBCs, suggesting a specificity to the calcitriol-mediated 186 inhibition of phagocytosis by human MDMs (Fig. 2G ). 187
Calcitriol downregulates the expression of antigen presentation molecules: Engagement of the 188 adaptive immune system through the re-activation of anti-myelin T-cell responses in the CNS 189 acts as a key pathogenic step in the initiation and exacerbation of MS (22). Activation of CD8 + 190 and CD4 + T-cells requires recognition of cognate antigens loaded on the surface of antigen-191 presenting cells (APCs). The strongest MS risk loci maps to the human leukocyte antigen (HLA) 192 region, which is a gene complex encoding the major histocompatibility family of proteins 193 (MHC). GWAS has identified the HLA-DRB1 as the strongest risk locus, conferring a 3-fold 194 increased MS risk (23).
Activation of T-cells requires expression of MHC class molecules by 195
APCs (signal one) in addition to a "second" signal in the form of expression of costimulatory 196 molecules such as CD40 and CD86, both also identified as MS risk loci (24) (25) (26) . IPA analysis of 197 our sequencing results highlights the "antigen presentation pathway" as a significantly affected 198 pathway (supplementary Fig. 2) , with downregulation of both MHC class I and II molecules as 199 indicated using the pathway visualization tool (Fig. 3A ). We identified a list of 24 genes 200 associated with antigen presentation in our dataset and assessed expression in response to 201 calcitriol in MØ 0 and MØ GMcsf cells (Fig. 3B ). Expression of a large number of HLA/MHC genes 202 were downregulated by calcitriol treatment in both cellular phenotypes, including the major MS 203 risk gene, HLA-DRB1. We validated these sequencing findings by measuring protein expression 204 using flow cytometry. Protein expression of both MHC class I (HLA-ABC) and MHC class II 205 (HLA-DR/DP/DQ) molecules were downregulated by calcitriol treatment in both MØ 0 and 206 MØ GMcsf cells ( Fig. 3C ). Expression of co-stimulatory molecules CD86 and CD40 were also 207 significantly reduced in response to calcitriol ( Fig. 3D ). Interestingly, we observed increased 208 expression of immune checkpoint molecule CD274 both at the mRNA ( shown that the human CD274 gene is a direct target of the 1,25(OH) 2 D-regulated VDR (28). 212 Finally, a "third" signal in the form of proinflammatory cytokine release from the APC is 213 suggested to be necessary for the induction of T-cell proliferation. IL-6 is a cytokine that when 214 released from APCs can promote the differentiation of IL-17-producing Th-17 cells, known to be 215 highly pathogenic in MS (29). We observed a significant decrease in IL-6 mRNA and protein 216 release by ELISA in response to calcitriol ( in vivo circulating concentrations of calcitriol (40-100pM) are much lower than those of 25OHD 220 (20-150nM). It is therefore important to determine whether there is sufficient intracellular 221 metabolism of 25OHD to calcitriol within MDMs to affect MerTK expression. As shown in Fig.  222 4A, proinflammatory MØ GMcsf cells exhibited the highest expression of the calcitriol-producing 223 enzyme, CYP27B1 (Fig. 4E ). This high level of CYP27B1 expression negatively correlated with 224 MERTK expression. Cells that expressed the lowest levels of MERTK (MØ GMcsf ) expressed the 225 highest levels of CYP27B1 and conversely, cells (MØ 0 ) that expressed the highest levels of 226 MERTK displayed the lowest expression of CYP27B1 (Fig. 4A, B ). CYP27B1 expression is 227 regulated by a complex network of cytokines (4); we therefore assessed the impact of 228 proinflammatory cytokines known to play a role in MS pathology (TNF-α and IL-1β) on 229 CYP27B1 expression, 25OHD metabolism, and MerTK expression (30). We observed that the 230 addition of TNF-α, and to a lesser degree IL-1β, enhanced the expression of CYP27B1 in 231 MØ GMcsf cells but not MØ 0 (Fig. 4C ). To assess the capacity of the vitamin D metabolic pathway 232 to regulate MerTK expression, cells were treated with the major circulating metabolite 25OHD. 233
Despite the increased basal expression of CYP27B1 in MØ GMcsf cells, exposure to 25OHD did 234 not significantly alter MerTK expression ( Fig. 4D ). However, combinatorial treatment of MDMs 235 with 25OHD and TNF-α (and to a lesser degree IL-1β) selectively and significantly 236 downregulated MerTK expression in MØ GMcsf cells to a similar degree as calcitriol ( Fig. 4D) . MDMs, both resident microglia and astrocyte populations take part in the neuroinflammatory 243 process and the phagocytic clearance of myelin debris. We therefore examined the effect of 244 calcitriol on human microglia isolated from resected brain tissue and astrocytes derived from the 245 fetal human CNS. Microglia were polarized to CNS homeostatic (MG 0 ) and proinflammatory 246 (MG GMcsf ) phenotypes. Similar to MDMs, cells were exposed to M-CSF (MG 0 ) or GM-CSF 247 (MG GMcsf ) over a 6-day period with homeostatic cells receiving additional TGFβ. Confirmation 248 of these phenotypes is highlighted by expression of established CNS homeostatic markers, 249
including microglia-specific markers TMEM119, SALL1 and OLFML3 (supplementary Fig. 1C ). 250 Proinflammatory microglia are characterized by high expression of canonical inflammatory 251 myeloid markers including genes that show relative specificity to microglia, CCL17 and IL1α 252 (supplementary Fig. 1D ). Bulk RNA sequencing was carried out on calcitriol-treated MG 0 and 253 MG GMcsf cells. PCA of these samples showed that, similar to MDMs, microglia cluster along the 254 1 st principal component based on their cellular phenotype (MG 0 and MG GMcsf ) and along the 2 nd 255 principal component based on treatment with calcitriol ( Fig. 5A ). ORA carried out on 256 differentially-expressed genes in both phenotypes exposed to calcitriol show a similar pattern of 257 calcitriol-responsive biological processes, including "inflammatory response" and "cytokine 258 production/secretion" (Fig. 5B ). These transcriptomic results were validated in vitro whereby 259 calcitriol downregulated MERTK mRNA and MerTK protein in human microglia ( Fig. 5C ). 260
Finally, calcitriol had no influence on MerTK mRNA or protein expression in human fetal 261 astrocytes ( Fig. 5D ), indicating that the regulation of MerTK expression by calcitriol is specific 262 to cells of the myeloid lineage. 263 264 Discussion 265
In this study, we set out to identify compounds that could modulate expression of the phagocytic 266 receptor tyrosine kinase MerTK, previously shown to positively regulate myelin phagocytosis 267 and efferocytosis (6, 31). Using the cytoscape plugin iCTNet to generate a drug-gene/target 268 network we identified calcitriol, the biologically-active form of vitamin D, as a compound that 269 interacts with the MERTK gene. Here we report that calcitriol controls expression of MerTK and 270 subsequent uptake of myelin debris and apoptotic cells by human myeloid cells. Calcitriol also 271 establishes an immune-regulatory phenotype in these cells, significantly reducing expression of 272 inflammatory mediators and antigen presentation machinery while increasing the expression of 273 immune checkpoint molecules. 274
275
Myelin clearance is essential for remyelination and CNS repair (32). We and others have 276 intracellular conversion of 25OHD is dependent on sufficient expression of the enzyme 309 CYP27B1 (2). Based on our findings we would predict that circulating 25OHD may not be as 310 important as the CYP27B1-mediated production of intracellular calcitriol and subsequent 311 transcriptional regulation of cellular function. Therefore, supplementation which increases serum 312 25OHD levels may not be targeting the cellular functions relevant to the pathogenesis of MS. 313 Carlberg and Hag propose the use of a "vitamin D response index" to aid in the administration of 314 personalized vitamin D supplementation protocols to obtain optimal vitamin D status. Such an 315 index may assist in the future stratification of study cohorts. Based on our results we would also 316 propose that an individual's ability to respond to vitamin D supplementation may fluctuate with 317 time, based on their inflammatory status and their cells' abilities to produce active calcitriol from 318 circulating 25OHD. 319 320 In addition to myelin debris, impaired clearance of cells undergoing apoptosis leads to sustained 321 proinflammatory responses, as cells progress to secondary necrosis (38). Digestion of 322 phagocytosed substrate and presentation as antigens loaded on MHC molecules (signal 1), 323 coupled with co-stimulation (signal 2) and secretion of inflammatory cytokines (signal 3) from 324
APCs play a critical role in stimulating the adaptive immune response (39). GWAS has 325 identified an extended HLA haplotype, HLA DRB1*15:01, DQA1*0102, DQB1*0602, within the 326 MHC class II region that is strongly associated with MS risk. In accordance with previous 327 reports, we observed that calcitriol downregulated the expression of both MHC class I and II 328 molecules on the surface of myeloid cells including HLA DRB1/DQA1/DQB1. Calcitriol 329 downregulated the expression of major costimulatory molecules and upregulated immune 330 checkpoint molecule CD274, as previously reported (28). Calcitriol also inhibited IL-6 331 expression and release. These combined data highlight the ability of calcitriol to modulate both 332 the ingestion of material and the expression of molecular machinery involved in antigen 333 presentation, potentially lowering the risk of auto-antigen presentation to the adaptive immune 334 system. 335
336
Our data shows that calcitriol downregulates MerTK expression and MerTK-mediated 337 phagocytosis in primary human myeloid cells. Intracellular production of active calcitriol from 338 its inactive precursor and resultant repression of MerTK is limited to proinflammatory myeloid 339 cells. This proinflammatory-specific effect may underlie a beneficial mechanism of vitamin D in 340 MS. Proinflammatory myeloid cells are potent antigen presenters; selective inhibition of myelin 341 uptake by these cells may lower the risk of myelin antigen presentation to infiltrating T-cells. In 342 contrast, maintenance of MerTK and therefore phagocytic function in homeostatic myeloid 343 populations (due to low expression of CYP27B1) would allow these cells to maintain clearance 344 of myelin debris and contribute to the process of repair. Overall, we uncover a functional 345 interaction between one of the strongest environmental modulators of MS risk (vitamin D) and 346 the MerTK pathway that is selective to disease-relevant populations of primary human myeloid 347 cells. Further understanding of the interplay between MS risk factors (both genetic and 348 environmental) will be crucial in identifying both the correct pathways and the correct timing at 349 which to target these pathways therapeutically. to calcitriol due to low expression of CYP27B1 and therefore maintain MerTK expression and function. However, proinflammatory MØ GMcsf cells express high levels of CYP27B1 and are thus able to produce calcitriol from its precursor, downregulate MerTK, molecules associated with antigen presentation, and inhibit phagocytosis. 
